Elevated expression of interleukin‐7 receptor in inflamed joints mediates interleukin‐7–induced immune activation in rheumatoid arthritis
- 27 August 2009
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (9), 2595-2605
- https://doi.org/10.1002/art.24754
Abstract
To evaluate the expression and functional ability of the high-affinity interleukin-7 receptor (IL-7Rα) in patients with rheumatoid arthritis (RA). Expression of IL-7Rα and IL-7 was determined in synovial tissue from RA patients and was compared with that in synovial tissue from patients with undifferentiated arthritis (UA) and osteoarthritis (OA). IL-7Rα expression on CD4 T cells, CD19 B cells, and CD14 monocyte/macrophages from RA synovial tissue, synovial fluid, and peripheral blood was also assessed. The proliferative capacity of IL-7Rαbright and IL-7Rαdim/− T cells was measured. In addition, we examined IL-7R blockade with soluble human IL-7Rα (hIL-7Rα) in the prevention of immune activation of peripheral blood mononuclear cells. We found significantly higher IL-7Rα expression in RA and UA synovial tissue than in OA synovial tissue, and the level of IL-7Rα expression correlated significantly with the levels of CD3 and IL-7 expression. CD4 T cells from RA synovial fluid and synovial tissue strongly expressed IL-7Rα. A substantial percentage of B cells and macrophages from RA synovial fluid and synovial tissue also expressed IL-7Rα, although less prominently than T cells. We found that peripheral blood IL-7Rαbright T cells that did not express FoxP3 were highly proliferative as compared with IL-7Rαdim/− T cells that did express high levels of FoxP3. Soluble hIL-7Rα inhibited IL-7–induced proliferation and interferon-γ production by mononuclear cells from RA patients. Our data suggest that enhanced expression of IL-7Rα and IL-7 in RA patients contributes significantly to the joint inflammation by activating T cells, B cells, and macrophages. The inhibition of IL-7R–mediated immune activation by soluble hIL-7Rα further indicates an important role of IL-7Rα in inflammatory responses in RA, suggesting IL-7Rα as a therapeutic target for immunotherapy in RA.Keywords
This publication has 37 references indexed in Scilit:
- Persistence of interleukin 7 activity and levels on tumour necrosis factor blockade in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2007
- Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL‐7 in an in vitro model derived from human psoriatic arthritisThe Journal of Pathology, 2007
- Interleukin-7 induced immunopathology in arthritisAnnals Of The Rheumatic Diseases, 2006
- Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7–dependent homeostatic proliferation of CD4+ T cellsThe Journal of Experimental Medicine, 2006
- Thymic stromal lymphopoietin: master switch for allergic inflammationThe Journal of Experimental Medicine, 2006
- Is radiation synovectomy for arthritis of the knee more effective than intraarticular treatment with glucocorticoids? Results of an eighteen‐month, randomized, double‐blind, placebo‐controlled, crossover trialArthritis & Rheumatism, 2005
- Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patientsImmunological Reviews, 2005
- CD4+CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluidArthritis & Rheumatism, 2004
- Interleukin 7 Regulates the Survival and Generation of Memory CD4 CellsThe Journal of Experimental Medicine, 2003
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988